News

It is one thing to be bested by the mighty US clusters of Silicon Valley or Cambridge, but seeing a major technology investment go to the rural state of Mississippi is hard to swallow

Amid the 10th birthday celebrations, ERC president Jean-Pierre Bourguignon set down a marker for the future, suggesting the annual budget should rise to €4 billion over the next ten years.

The competition among cities vying to replace London as home of the drug regulator is hotting up. A decision on the new location could be announced before June

The number of EU approved drugs for treating rare diseases is increasing but high prices and restrictive reimbursement policies are preventing patients from getting access.

Although patient-reported outcomes (PROMs) are being promoted as a way to optimise treatment, it is not clear that patients and doctors agree on how PROMs are interpreted.

The OECD has launched an online consultation to get views on how to improve access to innovative therapies, whilst ensuring national drugs budgets do go through the roof.

Helping people with asthma take control of their own illness reduces symptoms, improves quality of life, reduces use of emergency health services and even prevents deaths, according to a review of 270 studies carried out by researchers in the UK.

‘This is the moment that if I was an investor I would double my bet on Europe,’ says Moedas, on the 10th anniversary of the European Research Council

Denmark was a leader in using primary care data to drive improvements in outcomes. The decision to take down the national database following security concerns was a major step backwards. Access must be restored says OECD